These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32781055)

  • 1. Interest of blood biomarkers to predict lesions in medical imaging in the context of mild traumatic brain injury.
    Bouvier D; Oris C; Brailova M; Durif J; Sapin V
    Clin Biochem; 2020 Nov; 85():5-11. PubMed ID: 32781055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood biomarkers of mild traumatic brain injury: State of art.
    Sapin V; Gaulmin R; Aubin R; Walrand S; Coste A; Abbot M
    Neurochirurgie; 2021 May; 67(3):249-254. PubMed ID: 33482234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
    Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
    Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confounding factors of the expression of mTBI biomarkers, S100B, GFAP and UCH-L1 in an aging population.
    Calluy E; Beaudart C; Alokail MS; Al-Daghri NM; Bruyère O; Reginster JY; Cavalier E; Ladang A
    Clin Chem Lab Med; 2024 Sep; 62(10):2062-2069. PubMed ID: 38643415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
    Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
    Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.
    Lagerstedt L; Egea-Guerrero JJ; Bustamante A; Montaner J; Rodríguez-Rodríguez A; El Rahal A; Turck N; Quintana M; García-Armengol R; Prica CM; Andereggen E; Rinaldi L; Sarrafzadeh A; Schaller K; Sanchez JC
    PLoS One; 2017; 12(4):e0175572. PubMed ID: 28419114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining H-FABP and GFAP increases the capacity to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.
    Lagerstedt L; Egea-Guerrero JJ; Bustamante A; Rodríguez-Rodríguez A; El Rahal A; Quintana-Diaz M; García-Armengol R; Prica CM; Andereggen E; Rinaldi L; Sarrafzadeh A; Schaller K; Montaner J; Sanchez JC
    PLoS One; 2018; 13(7):e0200394. PubMed ID: 29985933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects.
    Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U
    World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Biomarker S100B and Mild Traumatic Brain Injury: A Meta-analysis.
    Oris C; Pereira B; Durif J; Simon-Pimmel J; Castellani C; Manzano S; Sapin V; Bouvier D
    Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29716980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy.
    Amoo M; Henry J; O'Halloran PJ; Brennan P; Husien MB; Campbell M; Caird J; Javadpour M; Curley GF
    Neurosurg Rev; 2022 Apr; 45(2):1171-1193. PubMed ID: 34709508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study - "the PreTBI I study".
    Seidenfaden SC; Kjerulff JL; Juul N; Kirkegaard H; Møller MF; Münster AB; Bøtker MT
    Scand J Trauma Resusc Emerg Med; 2021 Jun; 29(1):75. PubMed ID: 34078435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Biomarkers for the Management of Mild Traumatic Brain Injury in Clinical Practice.
    Oris C; Kahouadji S; Bouvier D; Sapin V
    Clin Chem; 2024 Aug; 70(8):1023-1036. PubMed ID: 38656380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Using a Rapid Point of Care Test for Predicting Head Computed Tomography Lesions After Mild Traumatic Brain Injury in a Dutch Multi-Center Cohort.
    Chayoua W; Visser K; de Koning ME; Beishuizen A; IJmker R; van der Naalt J; Krabbe JG; van der Horn HJ
    J Neurotrauma; 2024 Jul; 41(13-14):e1630-e1640. PubMed ID: 38326742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Performance of Blood S100B in the Management of Patients Over 65 Years Old With Mild Traumatic Brain Injury.
    Oris C; Bouillon-Minois JB; Pinguet J; Kahouadji S; Durif J; Meslé V; Pereira B; Schmidt J; Sapin V; Bouvier D
    J Gerontol A Biol Sci Med Sci; 2021 Jul; 76(8):1471-1479. PubMed ID: 33647933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Assessment of Acute Blood Markers of Brain Injury in Sport-Related Concussion.
    Meier TB; Nelson LD; Huber DL; Bazarian JJ; Hayes RL; McCrea MA
    J Neurotrauma; 2017 Nov; 34(22):3134-3142. PubMed ID: 28699381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100B vs. "GFAP and UCH-L1" assays in the management of mTBI patients.
    Oris C; Bouillon-Minois JB; Kahouadji S; Pereira B; Dhaiby G; Defrance VB; Durif J; Schmidt J; Moustafa F; Bouvier D; Sapin V
    Clin Chem Lab Med; 2024 Apr; 62(5):891-899. PubMed ID: 38033294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting.
    Zimmer L; McDade C; Beyhaghi H; Purser M; Textoris J; Krause A; Blanc E; Pavlov V; Earnshaw S
    J Neurotrauma; 2023 Apr; 40(7-8):706-719. PubMed ID: 36267001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.
    Welch RD; Ayaz SI; Lewis LM; Unden J; Chen JY; Mika VH; Saville B; Tyndall JA; Nash M; Buki A; Barzo P; Hack D; Tortella FC; Schmid K; Hayes RL; Vossough A; Sweriduk ST; Bazarian JJ
    J Neurotrauma; 2016 Jan; 33(2):203-14. PubMed ID: 26467555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Glial and Neuronal Blood Biomarkers Compared With Clinical Decision Rules in Assessing the Need for Computed Tomography in Patients With Mild Traumatic Brain Injury.
    Papa L; Ladde JG; O'Brien JF; Thundiyil JG; Tesar J; Leech S; Cassidy DD; Roa J; Hunter C; Miller S; Baker S; Parrish GA; Davison J; Van Dillen C; Ralls GA; Briscoe J; Falk JL; Weber K; Giordano PA
    JAMA Netw Open; 2022 Mar; 5(3):e221302. PubMed ID: 35285924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Blood Biomarkers in the Assessment of Sports-Related Concussion-A Systematic Review in the Context of Their Biological Significance.
    OʼConnell B; Kelly ÁM; Mockler D; Orešič M; Denvir K; Farrell G; Janigro D; Wilson F
    Clin J Sport Med; 2018 Nov; 28(6):561-571. PubMed ID: 29035978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.